FDA approves Jubilant’s Amlodipine and Olmesartan Medoxomil Tablets

Jubilant Life Sciences Ltd, announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, has received Abbreviated New Drug Application (ANDA)  final  approval  for Amlodipine and Olmesartan Medoxomil Tablets 5mg/20mg 5mg/40mg, 10mg/20mg and 10mg/40mg, which are the generic version of Azor of Daiichi Sankyo, which is used for the treatment of hypertension.

This is the third approval that they have received from the USFDA during the current financial year. As on December 31,  2016, Jubilant Life Sciences had a total of 73 ANDAs for Oral Solids filed in the US, of which 49have been approved.